David Lynch
Neurology with Special Qualifications in Child Neurology · Philadelphia, PANPI 1578597209
Payments from drug & device makers
Across 363 payments — averaging $10,387 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- PTC Therapeutics, Inc.$2.3M
- Biogen$1.4M
- Takeda Pharmaceuticals U.S.A., Inc.$42K
- United Therapeutics Corporation$13K
- Biomarin Pharmaceutical Inc.$3K
- Intuitive Surgical$2K
- plus $500 from 1 others
Across 1 payment — averaging $685.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$685
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| PTC Therapeutics, Inc. | 325 | $2,304,666 |
| Biogen | 17 | $1,405,949 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $42,106 |
| United Therapeutics Corporation | 1 | $12,500 |
| Biomarin Pharmaceutical Inc. | 1 | $2,833 |
| Intuitive Surgical | 3 | $1,952 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $500 |
How this compares
$3,770,507 in reported general payments places this provider in the 95th percentile of 83 neurology with special qualifications in child neurology providers in Pennsylvania.
See all neurology with special qualifications in child neurology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology with special qualifications in child neurology in Philadelphia
- Adeline VanderverPhiladelphia$6.5M
- John BrandsemaPhiladelphia$4.5M
- Eric MarshPhiladelphia$1.9M
- Amy WaldmanPhiladelphia$1.6M
- Christina SzperkaPhiladelphia$1.2M
- Sabrina YumPhiladelphia$867K
- Alexandra KornbluhPhiladelphia$821K
- Susan MatesanzPhiladelphia$754K
- David BeardenPhiladelphia$540K
- Sameh MorkousPhiladelphia$516K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.